Literature DB >> 21242409

Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment.

Tiffany C Scharschmidt1, John M Yost, Sam V Truong, Martin Steinhoff, Kevin C Wang, Timothy G Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21242409      PMCID： PMC3692271          DOI： 10.1001/archdermatol.2010.413

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  4 in total

1.  Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea.

Authors:  Jonathan Wilkin; Mark Dahl; Michael Detmar; Lynn Drake; Matthew H Liang; Richard Odom; Frank Powell
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

Review 2.  Rosacea: I. Etiology, pathogenesis, and subtype classification.

Authors:  Glen H Crawford; Michelle T Pelle; William D James
Journal:  J Am Acad Dermatol       Date:  2004-09       Impact factor: 11.527

Review 3.  Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.

Authors:  Dirk Roosterman; Tobias Goerge; Stefan W Schneider; Nigel W Bunnett; Martin Steinhoff
Journal:  Physiol Rev       Date:  2006-10       Impact factor: 37.312

Review 4.  The molecular pathology of rosacea.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  J Dermatol Sci       Date:  2009-05-29       Impact factor: 4.563
  4 in total
  11 in total

Review 1.  Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Jerome Aubert; Mathias Sulk; Pawel Novak; Verena D Schwab; Christian Mess; Ferda Cevikbas; Michel Rivier; Isabelle Carlavan; Sophie Déret; Carine Rosignoli; Dieter Metze; Thomas A Luger; Johannes J Voegel
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

2.  [Rosacea. Systemic therapy with retinoids].

Authors:  A Thielitz; H Gollnick
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

Review 3.  Skin microbiome and mast cells.

Authors:  Satomi Igawa; Anna Di Nardo
Journal:  Transl Res       Date:  2017-03-23       Impact factor: 7.012

Review 4.  The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.

Authors:  Martin Schaller; Thomas Dirschka; Sol-Britt Lonne-Rahm; Giuseppe Micali; Linda F Stein Gold; Jerry Tan; James Del Rosso
Journal:  Acta Derm Venereol       Date:  2021-10-31       Impact factor: 3.875

Review 5.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

6.  Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea.

Authors:  Yumiko Muto; Zhenping Wang; Matthieu Vanderberghe; Aimee Two; Richard L Gallo; Anna Di Nardo
Journal:  J Invest Dermatol       Date:  2014-05-20       Impact factor: 8.551

Review 7.  Recent advances in understanding and managing rosacea.

Authors:  Joerg Buddenkotte; Martin Steinhoff
Journal:  F1000Res       Date:  2018-12-03

Review 8.  Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis.

Authors:  Yu Ri Woo; Yu Jin Han; Hei Sung Kim; Sang Hyun Cho; Jeong Deuk Lee
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

9.  Evaluation of fibromyalgia syndrome in patients with rosacea.

Authors:  Emine Müge Acar; Hilal Kaya Erdoğan; Senem Şaş; Ersoy Acer
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

Review 10.  Rosacea: a Clinical Review.

Authors:  Carsten Sauer Mikkelsen; Helene Ringe Holmgren; Petra Kjellman; Michael Heidenheim; Ari Kappinnen; Peter Bjerring; Theis Huldt-Nystrøm
Journal:  Dermatol Reports       Date:  2016-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.